Premier Biomedical, Inc. is a research-based firm that develops cures for Amyotrophic Lateral Sclerosis (ALS), Traumatic Brain Injury (TBI), Multiple Sclerosis (MS), Clinical Depression, Alzheimer’s Disease, Blood Sepsis, Atherosclerosis, and Cancer.
|HQ||Jackson Center, US|
Gross profit (Q3, 2018)
Gross profit margin (Q3, 2018), %
Net income (Q3, 2018)
Market capitalization (8-Oct-2018)
Premier Biomedical has 165 Twitter Followers. The number of followers has decreased 1% month over month and decreased 2.4% quarter over quarter
When was Premier Biomedical founded?
Premier Biomedical was founded in 2010.
What is Premier Biomedical revenue?
Latest Premier Biomedical annual revenue is $39.8 k.
Who are Premier Biomedical competitors?
Competitors of Premier Biomedical include Cesca Therapeutics, Celldex Therapeutics and Synthetic Biologics.
Where are Premier Biomedical offices?
Premier Biomedical has an office in Jackson Center.
How many offices does Premier Biomedical have?
Premier Biomedical has 1 office.